The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease

Clinics in Liver Disease

Volumn 20, Issue 2, 2016, Pages 325-338

  Goyal, Nidhi P ^a,b   Schwimmer, Jeffrey B ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Adolescents; Children; Epidemiology; Morbidity; Mortality; Nonalcoholic steatohepatitis; Obesity; Outcomes

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; BODY MASS; CANCER INCIDENCE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PNPLA3 GENE; PREGNANCY DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDERED BREATHING; VITAMIN D DEFICIENCY; ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; COMPLICATION; INFANT; LUNG DISEASES; METABOLIC DISEASES; NEWBORN; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DISEASE PROGRESSION; HUMANS; INFANT; INFANT, NEWBORN; LIVER CIRRHOSIS; LUNG DISEASES; METABOLIC DISEASES; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84949844091     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.10.003     Document Type: Review

References (59)

1. Brumbaugh D.E., Tearse P., Cree-Green M., et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr 2013, 162(5):930-936.e1.
2. Modi N., Murgasova D., Ruager-Martin R., et al. The influence of maternal body mass index on infant adiposity and hepatic lipid content. Pediatr Res 2011, 70(3):287-291.
3. Patel K.R., White F.V., Deutsch G.H. Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. J Pediatr Gastroenterol Nutr 2015, 60(2):152-158.
4. Nobili V., Bedogni G., Alisi A., et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child 2009, 94(10):801-805.
5. Schwimmer J.B., Deutsch R., Kahen T., et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118(4):1388-1393.
6. Beacher D.A., Ariza A.J., Fishbein M.H., et al. Screening for elevated risk of liver disease in preschool children (aged 2-5 years) being seen for obesity management. SAGE Open Med 2014, 2.
7. Quiros-Tejeira R.E., Rivera C.A., Ziba T.T., et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr 2007, 44(2):228-236.
8. Welsh J.A., Karpen S., Vos M.B. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013, 162(3):496-500.e1.
9. Patton H.M., Lavine J.E., Van Natta M.L., et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008, 135(6):1961-1971.e2.
10. Carter-Kent C., Brunt E.M., Yerian L.M., et al. Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2011, 52(2):190-197.
11. Schwimmer J.B., Zepeda A., Newton K.P., et al. Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. PLoS One 2014, 9(11):e112569.
12. Nobili V., Marcellini M., Devito R., et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006, 44(2):458-465.
13. Valenti L., Alisi A., Galmozzi E., et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52(4):1274-1280.
14. Bennett B., Larson-Meyer D.E., Ravussin E., et al. Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring) 2012, 20(2):371-375.
15. Ugalde-Nicalo P.A., Schwimmer J.B. On the origin of pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2015, 60(2):147-148.
16. Schwimmer J.B., Celedon M.A., Lavine J.E., et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009, 136(5):1585-1592.
17. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40(12):1461-1465.
18. Valenti L., Al-Serri A., Daly A.K., et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010, 51(4):1209-1217.
19. Rotman Y., Koh C., Zmuda J.M., et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010, 52(3):894-903.
20. Schwimmer J.B., Newton K.P., Awai H.I., et al. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013, 38(10):1267-1277.
21. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005, 42(3):641-649.
22. Xanthakos S.A., Jenkins T.M., Kleiner D.E., et al. High prevalence of nonalcoholic fatty liver disease in adolescents undergoing bariatric surgery. Gastroenterology 2015, 149(3):623-634.e8.
23. Mansoor S., Yerian L., Kohli R., et al. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci 2015, 60(5):1440-1447.
24. Kistler K.D., Molleston J., Unalp A., et al. Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010, 31(3):396-406.
25. Kerkar N., D'Urso C., Van Nostrand K., et al. Psychosocial outcomes for children with nonalcoholic fatty liver disease over time and compared to obese controls. J Pediatr Gastroenterol Nutr 2012, 56(1):77-82.
26. Nobili V., Alisi A., Grimaldi C., et al. Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity?. Pediatr Obes 2014, 9(5):e99-e102.
27. Berentzen T.L., Gamborg M., Holst C., et al. Body mass index in childhood and adult risk of primary liver cancer. J Hepatol 2014, 60(2):325-330.
28. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
29. Schwimmer J.B., Pardee P.E., Lavine J.E., et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008, 118(3):277-283.
30. Sartorio A., Del Col A., Agosti F., et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007, 61(7):877-883.
31. Cali A.M., Zern T.L., Taksali S.E., et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care 2007, 30(12):3093-3098.
32. Corey K.E., Vuppalanchi R., Vos M., et al. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2015, 60(3):360-367.
33. Demircioglu F., Koçyiğit A., Arslan N., et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008, 47(1):68-75.
34. Pacifico L., Cantisani V., Ricci P., et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008, 63(4):423-427.
35. Manco M., Bedogni G., Monti L., et al. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 2010, 209(2):463-468.
36. Sert A., Pirgon O., Aypar E., et al. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. J Pediatr Endocrinol Metab 2012, 25(9-10):927-934.
37. Singh G.K., Vitola B.E., Holland M.R., et al. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr 2013, 162(6):1160-1168. 1168.e1.
38. Pacifico L., Di Martino M., De Merulis A., et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014, 59(2):461-470.
39. Mathurin P., Durand F., Ganne N., et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995, 109(5):1682-1684.
40. Henrion J., Colin L., Schapira M., et al. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997, 24(4):245-249.
41. Sundaram S.S., Sokol R.J., Capocelli K.E., et al. Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. J Pediatr 2014, 164(4):699-706.e1.
42. Nobili V., Cutrera R., Liccardo D., et al. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. Am J Respir Crit Care Med 2014, 189(1):66-76.
43. Daniel J.L., Behling C., Proudfoot J., et al. Is sleep disordered breathing associated with non-alcoholic fatty liver disease in pediatric patients?. Am J Respir Crit Care Med 2015, 191:A5054.
44. Burgert T.S., Taksali S.E., Dziura J., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006, 91(11):4287-4294.
45. Nadeau K.J., Klingensmith G., Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005, 41(1):94-98.
46. Manco M., Marcellini M., Devito R., et al. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008, 32(2):381-387.
47. Schwimmer J.B., Deutsch R., Rauch J.B., et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003, 143(4):500-505.
48. Carter-Kent C., Yerian L.M., Brunt E.M., et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 2009, 50(4):1113-1120.
49. Pardee P.E., Dunn W., Schwimmer J.B. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther 2012, 35(2):248-254.
50. Pacifico L., Bezzi M., Lombardo C.V., et al. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease. World J Gastroenterol 2013, 19(25):4007-4014.
51. Manco M., Ciampalini P., Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 2010, 51(6):2229. [author reply: 2230].
52. Nobili V., Giorgio V., Liccardo D., et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol 2014, 170(4):547-553.
53. Hourigan S.K., Abrams S., Yates K., et al. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 2015, 60(3):396-404.
54. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009, 58(11):1538-1544.
55. Molleston J.P., White F., Teckman J., et al. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002, 97(9):2460-2462.
56. A-Kader H.H., Henderson J., Vanhoesen K., et al. Nonalcoholic fatty liver disease in children: a single center experience. Clin Gastroenterol Hepatol 2008, 6(7):799-802.
57. Alkhouri N., Hanouneh I.A., Zein N.N., et al. Su1038 Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in children and young adults: the true burden of pediatric nonalcoholic fatty liver disease. Gastroenterology 2015, 148(4):S-1046.
58. Brunt E.M., Kleiner D.E., Belt P.H., et al. Pediatric Nonalcoholic Fatty Liver Disease (NAFLD): histological feature changes over time in paired biopsies from the NASH CRN. Hepatology 2014, 60:290a.
59. Lavine J.E., Yates K.P., Brunt E.M., et al. The natural history of nonalcoholic fatty liver disease in children and adolescents assessed in placebo recipients in the TONIC trial. Hepatology 2012, 56:905a.